Analysis of endovascular therapy for femoropopliteal disease with the Supera stent

Montero-Baker, Miguel; Ziomek, Gregory J.; León, Luis R.; Gonzales, Aaron; Dieter, Robert S.; Gadd, Crystal L.; Pacanowski, John P.

doi:10.1016/j.jvs.2016.04.053

Cited by 32 publications

(9 citation statements)

References 17 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…After being acquired by Abbott in 2013, it gradually gained local popularity. The usage of interwoven helical stent increased in our cohort especially after several clinical studies, 7–13 including one local cohort study demonstrating the feasibility and acceptable result in elderly patients 8 …”

Section: Discussionmentioning

confidence: 91%

Three‐year comparable clinical outcome for Trans‐Atlantic Inter‐Society Consensus (TASC) D femoropopliteal occlusion: Endovascular vs bypass surgery

et al. 2023

View full text Add to dashboard Cite

Aim To evaluate the difference between endovascular surgery and bypass/hybrid approach in treating Trans‐Atlantic Inter‐Society Consensus (TASC) D femoropopliteal occlusion. Patients and Methods This is a 10‐year retrospective cohort study including 75 patients with TASC D femoropopliteal occlusion with revascularisation from 2009 to 2018. Cases were retrieved from the Clinical Data Analysis and Reporting System. Demographics, lesions characteristics, operative findings and follow‐up data were reviewed. Results A total of 65% of patients had endovascular intervention, 23% open bypass and 12% hybrid operation. The endovascular group had fewer critical limb ischaemia (endovascular 43%, bypass 94%, hybrid 100%; P < .001), and shorter length of lesion (endovascular 26.4 cm vs bypass/hybrid 31.0 cm; P = .004). The technical success rate of the endovascular group was 87.8%. Different endovascular treatment strategies were used. The 12‐month primary patency rate of the endovascular group was lower (endovascular 69.7% vs bypass 81.3% vs hybrid 75.0%; P = .67) but the secondary patency rate at 3 years after the operation was similar across all groups (endovascular 83.3% vs bypass 78.6% vs hybrid 87.5%; P = .86). Conclusion Endovascular treatment for long and complex femoropopliteal occlusion is technically feasible with a high success rate. Close surveillance with prompt reintervention may help achieve 3 years’ comparable patency of endovascular intervention to traditional surgical bypass. Individualised plan of revascularisation should be considered.

show abstract

Section: Discussionmentioning

confidence: 91%

Three‐year comparable clinical outcome for Trans‐Atlantic Inter‐Society Consensus (TASC) D femoropopliteal occlusion: Endovascular vs bypass surgery

et al. 2023

View full text Add to dashboard Cite

show abstract

“…Newer stents, with different radial strength and flexibility, have been developed for use in areas with extreme mobility demands, but they are still undergoing long-term assessment. 27 We consider that patients with involvement of the popliteal artery in the joint region are candidates for open surgery.…”

Section: Discussionmentioning

confidence: 99%

Tratamento da doença arterial obstrutiva periférica em território femoropoplíteo com stent primário: análise em até 24 meses

Geiger

Guillaumon

2019

J. vasc. bras.

View full text Add to dashboard Cite

Resumo Contexto O stent primário é uma opção de tratamento bem estabelecida para a doença arterial periférica em território femoropoplíteo. Estudos nacionais são escassos. Objetivos Avaliar desfechos clínicos e radiológicos em curto e médio prazo em pacientes classificados como Rutherford 3-6, tratados com o uso de stent em lesões femoropoplíteas. Métodos A análise foi realizada com base em um banco de dados prospectivamente mantido de doentes tratados entre julho de 2012 e julho de 2015. O objetivo primário foi a perviedade. Os objetivos secundários foram melhora na classificação de Rutherford, índice tornozelo/braço, revascularização do vaso-alvo, taxa de salvamento do membro e óbito em até 24 meses. Resultados Foram incluídos 64 pacientes, sendo 61 com lesões TASC II A/B (95%). A taxa de perviedade primária em 6, 12 e 24 meses foi de 95,2%, 79,1% e 57,9%, respectivamente. A análise de regressão de Cox revelou uma menor perviedade em pacientes com doença oclusiva (RR, 6,64, IC 95%, 1,52-28,99, p = 0,02), bem como uma perda de perviedade cerca de seis vezes maior em doentes TASC B do que TASC A (RR, 5,95, IC 95%, 1,67-21,3, p = 0,0061). Em 12 meses, 90,38% dos doentes permaneceram assintomáticos. A taxa de salvamento do membro em 24 meses foi de 94,3% (IC 95%, 87,9-100%). A ausência de revascularização do vaso-alvo em 24 meses foi de 90,5% (IC 95%, 82,8-98,9%). Conclusões Os resultados foram compatíveis com estudos internacionais, apesar do estágio mais avançado da doença vascular observada em nosso grupo. Piores desfechos foram associados a doença oclusiva e lesões complexas.

show abstract

“…Lastly, although this analysis reviewed various technologies, including percutaneous transluminal angioplasty, drug‐coated balloon angioplasty, bare‐metal stent, and directional atherectomy, other technologies such as stent‐grafts, drug‐eluting stent, and other atherectomy devices were unavailable for analysis. This limitation is relevant since evidence exists that even within these classes of devices, differences may exist among devices, for example, interwoven nitinol stents versus laser‐cut hypotube stents, and drug‐coated balloons of different drug compositions and excipient formulations . Thus, it is possible that these devices may exhibit distinct patterns of restenosis.…”

Section: Discussionmentioning

confidence: 99%

Angiographic classification of patterns of restenosis following femoropopliteal artery intervention: A proposed scoring system

Garcia

Rocha‐Singh

Ramanathan

et al. 2017

Cathet Cardio Intervent

View full text Add to dashboard Cite

show abstract

Analysis of endovascular therapy for femoropopliteal disease with the Supera stent

Cited by 32 publications

References 17 publications

Three‐year comparable clinical outcome for Trans‐Atlantic Inter‐Society Consensus (TASC) D femoropopliteal occlusion: Endovascular vs bypass surgery

Three‐year comparable clinical outcome for Trans‐Atlantic Inter‐Society Consensus (TASC) D femoropopliteal occlusion: Endovascular vs bypass surgery

Tratamento da doença arterial obstrutiva periférica em território femoropoplíteo com stent primário: análise em até 24 meses

Angiographic classification of patterns of restenosis following femoropopliteal artery intervention: A proposed scoring system

Contact Info

Product

Resources

About